Graf Akcie ABUS (Arbutus Biopharma Corp). Diskuze k akciím ABUS. Aktuální informace ABUS.

Základní informace o společnosti Arbutus Biopharma Corp (Akcie ABUS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 396.34M
Hodnota podniku (EV) 354.96M
Tržby 8.351M
EBITDA -65.46
Zisk -84.19
Růst v tržbách Q/Q 53.83 %
Růst v tržbách Y/Y 8.68 %
P/E (Cena vůči ziskům) N/A
Forward P/E -19.68
EV/Sales 42.50
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 47.46
P/FCF N/A
Price/Book 3.89
Účetní hodnota na akcii 1.04
Hotovost na akcii 1.26
FCF vůči ceně -15.13 %
Počet zaměstnanců 77
Tržba na zaměstnance 108.455k
Profit margin -921.97 %
Operating margin -775.57 %
Gross margin 100.00 %
EBIT margin -816.18 %
EBITDA margin -783.82 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -8.00 %
EPS - Očekávaný růst příští rok -11.11 %
Return on assets -52.07 %
Return on equity -69.10 %
ROIC -49.24 %
ROCE -53.87 %
Dluhy/Equity 0.34
Čistý dluh/EBITDA 6.72
Current ratio 9.44
Quick Ratio 9.44
Volatilita 6.09
Beta 1.14
RSI 49.49
Cílová cena analytiků 6
Známka akcie (dle analytiků) 1.40
Insider ownership 18.71 %
Institutional ownership 25.33 %
Počet akcií 99.161M
Procento shortovaných akcií 5.18 %
Short ratio 3.13 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2010
Země United States

Finanční výsledky akcie ABUS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$6.011$5.945$10.7$1.491$24.873$14.953
Cost Of Goods Sold------
Gross Profit$6.011$5.945$10.7$1.491$24.873$14.953
Research And Development Expenses$57.601$57.934$62.676$61.253$51.505$38.713
SG&A Expenses$17.727$16.002$16.129$39.438$26.438$8.683
Other Operating Income Or Expenses$-6.422$-4.797--$-9.656$-0.462
Operating Expenses$150.085$95.725$121.63$493.13$127.195$48.387
Operating Income$-144.074$-89.78$-110.93$-491.639$-102.322$-33.434
Total Non-Operating Income/Expense$-22.305$28.438$2.197$2.473$25.016$-5.403
Pre-Tax Income$-166.379$-61.342$-108.733$-489.166$-77.306$-38.837
Income Taxes$-12.656$-4.282$-24.32$-105.002$-16.185-
Income After Taxes$-153.723$-57.06$-84.413$-384.164$-61.121$-38.837
Other Income------
Income From Continuous Operations$-153.723$-57.06$-84.413$-384.164$-61.121$-38.837
Income From Discontinued Operations------
Net Income$-164.872$-67.151$-85.324$-384.164$-61.121$-38.837
EBITDA$-75.739$-72.788$-68.105$-99.2$-62.726$-32.905
EBIT$-144.074$-89.78$-110.93$-491.639$-102.322$-33.434
Basic Shares Outstanding575555534522
Shares Outstanding575555534522
Basic EPS$-2.89$-1.21$-1.56$-7.24$-1.34$-1.80
EPS - Earnings Per Share$-2.89$-1.21$-1.56$-7.24$-1.34$-1.80
# 2020 2019 2018 2017 2016 2015
Current Ratio11.986211.49838.844312.523817.38345.7616
Long-term Debt / Capital--0.06170.0558--
Debt/Equity Ratio--0.06580.0591--
Gross Margin100100100100100100
Operating Margin-2396.839-1510.177-1036.729-32973.77-411.3778-223.5939
EBIT Margin-2396.839-1510.177-1036.729-32973.77-411.3778-223.5939
EBITDA Margin-1260.007-1224.356-636.4953-6653.251-252.1851-220.0562
Pre-Tax Profit Margin-2767.909-1031.825-1016.196-32807.91-310.8029-259.7271
Net Profit Margin-2742.838-1129.537-797.4205-25765.52-245.7323-259.7271
Asset Turnover0.0570.02610.04510.00540.03490.1265
Inventory Turnover Ratio------
Receiveable Turnover4.99254.154414.42052.634319.83497.5178
Days Sales In Receivables73.109387.857925.3112138.55818.401948.5511
ROE - Return On Equity238.1785-77.0061-63.6153-189.2386-11.16-44.1154
Return On Tangible Equity-211.3205-42.6053-84.8696-485.08-187.9316-44.1154
ROA - Return On Assets-145.6607-25.0368-35.5931-139.2307-8.5809-32.8631
ROI - Return On Investment-211.3205-28.4967-43.4058-178.6759-11.16-44.1154
Book Value Per Share1.12293.60663.3143.701710.03633.9235
Operating Cash Flow Per Share-0.0166-0.33830.20180.1145-0.6301-0.1347
Free Cash Flow Per Share-0.0065-0.22580.1440.0899-0.6353-0.1325

Porovnání s konkurencí: Akcie ABUS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ABUS N/A N/A 8.68 % -11.11 % -69.10 % 3.89 -921.97 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie ABUS

Jméno Obchod Cena Objem
Michael J. Sofia
Chief Scientific Officer
Prodej
15 Aug 2017
$3.70 $111,000
Michael J. Sofia
Chief Scientific Officer
Prodej
3 Oct 2017
$8.00 $80,000
Mark J. Murray
President and CEO
Option
16 Apr 2018
$0.35 $9,452
Michael J. Sofia
Chief Scientific Officer
Prodej
3 Jul 2018
$8.20 $164,000
Michael J. Sofia
Chief Scientific Officer
Prodej
6 Jul 2018
$8.68 $173,600
Michael J. Sofia
Chief Scientific Officer
Prodej
11 Jul 2018
$10.00 $100,000
Michael J. Sofia
Chief Scientific Officer
Prodej
13 Aug 2018
$9.51 $40,418
Mark J. Murray
President and CEO
Option
28 Nov 2018
$1.35 $33,750
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
23 Jul 2020
$5.01 $100,200
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
14 Dec 2020
$5.00 $200,000
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
9 Feb 2021
$5.00 $100,000
Michael J. Sofia
Chief Scientific Officer
Prodej
15 Aug 2017
$3.70 $111,000
Michael J. Sofia
Chief Scientific Officer
Prodej
3 Oct 2017
$8.00 $80,000
Mark J. Murray
President and CEO
Option
16 Apr 2018
$0.35 $9,452
Michael J. Sofia
Chief Scientific Officer
Prodej
3 Jul 2018
$8.20 $164,000
Michael J. Sofia
Chief Scientific Officer
Prodej
6 Jul 2018
$8.68 $173,600
Michael J. Sofia
Chief Scientific Officer
Prodej
11 Jul 2018
$10.00 $100,000
Michael J. Sofia
Chief Scientific Officer
Prodej
13 Aug 2018
$9.51 $40,418
Mark J. Murray
President and CEO
Option
28 Nov 2018
$1.35 $33,750
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
23 Jul 2020
$5.01 $100,200
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
14 Dec 2020
$5.00 $200,000
Michael J. Mc Elhaugh
Chief Business Officer
Prodej
9 Feb 2021
$5.00 $100,000

Diskuze k akciím ABUS